What does this research mean for the field?

A bioadaptive nanomedicine sequentially delivering NAD+ and genipin promotes functional cardiac recovery after myocardial infarction through coordinated mitochondrial protection and metabolic repair. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

Determine whether a bioadaptive nanomedicine can sequentially target dynamic metabolic changes in injured myocardium to promote functional cardiac recovery.

This research is Trending!

September 25, 2026Nature Cardiovascular Research

Timed metabolic repair after myocardial infarction

View Full Paper

Ask AI

Bookmark

Key result

A bioadaptive nanomedicine sequentially delivering NAD+ and genipin promoted functional cardiac recovery after myocardial infarction through mitochondrial protection and metabolic repair.

Population

Myocardial infarction model (implied preclinical)

Design

Editorial

Authors

CCChak Kwong ChengMax Planck Institute for Heart and Lung Research YHYü HuangBGI Group (China)

Discussion

Member takes

Implication

A novel bioadaptive nanomedicine delivering NAD+ and genipin shows promise for metabolic repair and functional recovery after myocardial infarction.

Key Points

Determine whether a bioadaptive nanomedicine can sequentially target dynamic metabolic changes in injured myocardium to promote functional cardiac recovery.
Engineered a bioadaptive nanomedicine designed for time-dependent drug delivery.
Programmed the carrier to sequentially administer nicotinamide adenine dinucleotide (NAD+) followed by genipin to target consecutive metabolic recovery stages.
Sequential delivery successfully coordinated initial mitochondrial protection with subsequent metabolic repair in damaged heart tissue.
The dual-stage metabolic intervention significantly enhanced overall functional recovery of the heart following infarction.

Structured PICO

Population

Myocardial infarction model (implied preclinical)

Intervention

Bioadaptive nanomedicine sequentially delivering NAD+ and genipin

Outcome

Functional recovery of the heartsurrogate

A novel bioadaptive nanomedicine delivering NAD+ and genipin shows promise for metabolic repair and functional recovery after myocardial infarction.

Cite This Study

Cheng et al. (2026) studied this question. A bioadaptive nanomedicine sequentially delivering NAD+ and genipin promoted functional cardiac recovery after myocardial infarction through mitochondrial protection and metabolic repair.

synapsesocial.com/papers/6ab61496406bf401c146a37f https://doi.org/10.1038/s44161-026-00873-9

Topics

Heart failure HFrEF treatment

View Full Paper

Ask AI

Bookmark

Implication

A novel bioadaptive nanomedicine delivering NAD+ and genipin shows promise for metabolic repair and functional recovery after myocardial infarction.

Timed metabolic repair after myocardial infarction

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Timed metabolic repair after myocardial infarction

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider